期刊文献+

药物间置换相互作用的毛细管电泳迎头分析法研究 被引量:1

Study on Drug Displacement Interactions by Capillary Electrophoresis-Frontal Analysis
下载PDF
导出
摘要 将 18 甲基炔诺酮加到人血清白蛋白 酮洛芬平衡溶液中,室温孵育达平衡后应用毛细管电泳 迎头分析法研究了 18 甲基炔诺酮和酮洛芬在人血清白蛋白分子上的置换相互作用。一大体积样品虹吸进样至未涂层毛细管(65cm×50μmi d ,有效长度 35cm),进样时间 80s,毛细管两端高度差 11cm,工作电压 10kV,运行缓冲液为67mmol/L磷酸盐缓冲液(pH7 4),游离酮洛芬浓度由前沿峰的高度直接测定。当酮洛芬样品溶液中酮洛芬的总浓度分别为 100μmol/L和 200μmol/L时,随着 18 甲基炔诺酮加入量的增加 (18 甲基炔诺酮的浓度由 0增至 200μmol/L),游离酮洛芬的浓度分别从 22 4增至 26 4μmol/L和从 82 1增至 106 2μmol/L。由上面的结果可推论:高浓度的 18 甲基炔诺酮可将酮洛芬从它的第二类结合位点上置换出来。 The interaction between 18-methyl norethindrone and ketoprofen including the displacement of ketoprofen from human serum albumin binding sites was investigated by capillary electrophoresis-frontal analysis method (CE-FA) at room temperature. A very large sample plug was introduced hydrostatically into the capillary (65 cm×50 μm i.d., effective length of 35 cm) over 80 s at a height difference of 11 cm. The working conditions for CE-FA separation are as follows: operating voltage, 10 kV; running buffer, 67 (mmol/L) phosphate, pH 7.4. The unbound ketoprofen concentration was directly measured from the height of the frontal peak. When the concentration of 18-methyl norethindrone was increased from 0 to 200 (μmol/L), the unbound ketoprofen concentration was found to increase from 22.4 to 26.4 (μmol/L) at 100(μmol/L) total ketoprofen concentration and from 82.1 to 106.2 (μmol/L) at 200 (μmol/L) total ketoprofen concentration. From these data, it may be deduced that the administration of high concentration of 18-methyl norethindrone could displace ketoprofen from its (secondary) binding site.
出处 《色谱》 CAS CSCD 北大核心 2005年第2期186-188,共3页 Chinese Journal of Chromatography
基金 国家自然科学基金资助项目(批准号: 29975018).
关键词 毛细管电泳-迎头分析 人血清白蛋白 置换相互作用 capillary electrophoresis-frontal analysis human serum albumin displacement (interaction)
  • 相关文献

参考文献14

  • 1Pouplana R, Lozano J J, Ruiz J. J Mol Graphics Modell, 2002, 20(4): 329.
  • 2Miranda H F, Sierralta F, Pinardi G. Br J Pharmacol, 2002, 135(7): 1591.
  • 3Walle U K, Fagan T C, Topmiller M J, Conradi E C, Walle T. Br J Clin Pharmacol, 1994, 37: 21.
  • 4Yu H Y, Shen Y Z. J Formosan Med Assoc, 1999, 98(3): 201.
  • 5Wang H L, Zou H F, Zhang Y K. Anal Chem, 1998, 70(2): 373.
  • 6Yamasaki K, Rahman M H, Tsutsumi Y, Maruyama T, Ahmed S, Kragh-Hansen U, Otagiri M. AAPS PharmSciTech, 2000, 1(2): E12.
  • 7Shimura K, Kasai K I. Anal Biochem, 1997, 251(1): 1.
  • 8Busch M H A, Carels L B, Boelens H F M, Kraak J C, Poppe H. J Chromatogr A, 1997, 777: 311.
  • 9Sihvo S, Klaukka T, Martikainen J, Hemminki E. Eur J Clin Pharmacol, 2000, 56: 495.
  • 10Miranda H F, Sierralta F, Pinardi G. Br J Pharmacol, 2002, 135: 1591.

同被引文献5

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部